Oaktree Acquisition Corp. III Life Sciences (OACC) Stock Profile — Insider Trades & Financials

Net Income$1.8M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Zaid Pardesi

CEO & Executive Director

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Founded: 2024
Headquarters: Los Angeles, California, United States
Website: www.oaktreeacquisitioncorp.com/oac-iii

⚡

Core Efficiency

ROE?

-26.42%

ROA?

0.88%

D/E Ratio?

-1.23

📊

Profitability Ratios

Current Ratio?

1.19

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Jun 25, 2026 (in 79 days)

Annual Report (10-K) — Based on filing pattern

Jun 25, 2026

Predicted10-K

Mar 26, 2026

10-KQ4 202585d after period end

Mar 26, 2026

10-KFY 202585d after period end

Nov 13, 2025

10-QQ3 202544d after period end

Aug 12, 2025

10-QQ2 202543d after period end

May 14, 2025

10-QQ1 202544d after period end

Mar 27, 2025

10-KFY 202586d after period end

Loading company sections...

Oaktree Acquisition Corp. III Life Sciences

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness